Treatment stratification of respiratory syncytial virus infection in allogeneic stem cell transplantation

Allogeneic haematopoietic stem cell transplantation (allo-HSCT) remains the only curative treatment for many haematological conditions.1 Despite gradually improving outcomes over time the success of the procedure is hindered by infectious complications that along with graft-versus-host disease (GVHD) remain the main cause of non-relapse morbidity and mortality.2,3

Source: Journal of Infection - April 11, 2019 Category: Infectious Diseases Authors: Katalin Balassa, Richard Salisbury, Edmund Watson, Marcin Lubowiecki, Bing Tseu, Nadjoua Maouche, Katie Jeffery, Siraj A. Misbah, Rachel Benamore, Lara Rowley, Daja Barton, Rachel Pawson, Robert Danby, Vanderson Rocha, Andy Peniket Source Type: research